Notably, diminished FXR expression in the prefrontal cortex has been observed in depressive mouse models, and its modulation significantly influences depression-related behaviors, identifying FXR as a promising therapeutic target (Bao et al., 2021). The gene discussed is NR1H4; the disease is depressive disorder.